Page URL: https://www.bionews.org.uk/page_95495

Gene therapy reverses inherited blindness

3 May 2016
Appeared in BioNews 849

A trial of gene therapy for choroideremia, a rare form of inherited blindness, has partially restored the vision of several patients.

These improvements to vision have lasted at least four years, and it is hoped that the technique could be extended to other more common forms of inherited blindness.

'There have recently been questions about the long-term efficacy of gene therapy, but now we have unequivocal proof that the effects following a single injection of viral vector [carrying the genes] are sustained,' said Professor Robert MacLaren of Oxford University, who led the study.

His team treated six patients with choroideremia, which affects around 1 in 50,000 people. The condition is caused by a mutation of the CHM (Choroideremia (Rab Escort Protein 1)) gene, which results in progressive damage to light-responsive retinal cells. The team used a harmless virus to inject a properly functioning version of the CHM gene into the retina to try to stimulate the regeneration of cells and halt visual loss.

The study, which was published in the New England Journal of Medicine, found significant improvements in the vision of two out of the six patients treated, and these have lasted nearly four years. As the vision in their treated eye improved, their untreated eye showed continued deterioration. Three patients, who were less severely affected by the disorder, also displayed preserved vision over the same time period.

'To permanently restore sight to people with inherited blindness would be a remarkable medical achievement. This is the first time we've seen what appears to be a permanent change in vision after just one round of treatment,' said Dr Stephen Caddick of the Wellcome Trust, which partly funded the study.

Jonathan Wyatt, the first patient to be treated with the gene therapy, has maintained twice the level of vision in his treated eye. 'The left eye is much improved to such an extent that I use it mostly to get about these days… Without it I think I would be tapping with a white stick.'

If the next round of clinical trials is successful, gene therapy for choroideremia could be available within the next three years, and the technique could be extended to other inherited forms of blindness, such as retinitis pigmentosa and genetic-related macular degeneration. Although these disorders have a more complex genetic basis than choroideremia, Professor MacLaren is already preparing for clinical trials as early as next year, with the potential for treatments in the next five to ten years.

'As we learn more about genetics we realise that correcting faulty genes even before a disease starts may be the most effective treatment. This is the breakthrough we have all been waiting for,' said Professor MacLaren.

Chief executive of the UK charity RP Fighting Blindness, Tina Houlihan, commented: 'Advances made in genetic therapies are extremely encouraging for people living with inherited eye conditions. We look forward to even greater steps forward being made in the future as treatments are refined ever further.'

SOURCES & REFERENCES
Gene Therapy for Choroideremia Improves Vision After 3.5 Years
Medscape |  27 April 2016
Gene therapy reverses sight loss and is long-lasting
BBC News |  28 April 2016
Gene therapy shows long-term benefit for treating rare blindness
Eurekalert (press release) |  28 April 2016
New gene therapy treatment boosts quest for vision loss cures
The Guardian |  28 April 2016
Visual Acuity after Retinal Gene Therapy for Choroideremia
New England Journal of Medicine |  27 April 2016
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
16 October 2017 - by Rikita Patel 
The US Food Drug and Administration advisory committee has backed the use of gene therapy to treat a hereditary disease for the first time...
9 October 2017 - by Dr Kimberley Bryon-Dodd 
Gene therapy has restored some vision in mice blinded by retinitis pigmentosa, an inherited degenerative eye disease...
21 November 2016 - by Paul Waldron 
Scientists in the US have used a genome-editing technique to partially restore vision in blind rats...
12 September 2016 - by Dr Nicoletta Charolidi 
A genetically engineered virus that triggers the production of an alternative form of haemoglobin has reversed the symptoms of sickle cell disease in mice...
14 March 2016 - by Kulraj Singh Bhangra 
Scientists have shown that stem cells found in the eye can restore vision in children with cataracts...
1 February 2016 - by Kulraj Singh Bhangra 
Researchers have used the CRISPR/Cas9 genome-editing technique to correct a genetic mutation that causes blindness...
24 August 2015 - by Antony Blackburn-Starza 
An experimental form of gene therapy to treat blindness has been showed to restore some vision in mice....
15 December 2014 - by Dr Rosie Gilchrist 
Scientists have used gene therapy to restore some sight to animals with visual impairment similar to retinosa pigmentosa, a type of human blindness...
16 January 2014 - by Siobhan Chan 
Gene therapy for an eye condition called choroideremia is safe and has improved the vision of six patients, says a study in the Lancet...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.